Proteasome Inhibitors [MoA] - N0000175075

Name: Table of NDC products with proteasome inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175075
Pharmacologic Name	Proteasome Inhibitors
Pharmacologic Uses	proteasome inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Proteasome Inhibitors

The table contains 34 products whose active ingredient are classified under the same pharmacologic class Proteasome Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0143-9098	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
0409-1700	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Hospira, Inc.	ACTIVE
0409-1703	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Hospira, Inc.	ACTIVE
0409-1704	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Hospira, Inc.	ACTIVE
0781-3258	Bortezomib	Non-Proprietary Name: Bortezomib For Injection	Injection, Powder, Lyophilized, For Solution	Intravenous	Sandoz Inc	ACTIVE
10019-991	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Baxter Healthcare Corporation	ACTIVE
25021-244	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
43598-426	Bortezomib	Non-Proprietary Name: Bortexomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Dr.reddy's Laboratories, Inc.	ACTIVE
43598-865	Bortezomib	Non-Proprietary Name: Bortexomib	Injection, Powder, Lyophilized, For Solution	Intravenous	Dr.reddy's Laboratories Inc	ACTIVE
50742-484	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Ingenus Pharmaceuticals, Llc	ACTIVE
51817-586	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Pharmascience Inc.	ACTIVE
55150-337	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Eugia Us Llc	ACTIVE
60505-6050	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Apotex Corp	ACTIVE
63020-049	Velcade	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE
63020-230	Ninlaro	Non-Proprietary Name: Ixazomib	Capsule	Oral	Takeda Pharmaceuticals America, Inc.	ACTIVE
63020-390	Ninlaro	Non-Proprietary Name: Ixazomib	Capsule	Oral	Takeda Pharmaceuticals America, Inc.	ACTIVE
63020-400	Ninlaro	Non-Proprietary Name: Ixazomib	Capsule	Oral	Takeda Pharmaceuticals America, Inc.	ACTIVE
63323-821	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
67184-0530	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Qilu Pharmaceutical Co., Ltd.	ACTIVE
68001-534	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Bluepoint Laboratories	ACTIVE
68001-540	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Bluepoint Laboratories	ACTIVE
68001-541	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Bluepoint Laboratories	ACTIVE
70511-161	Bortezomib	Non-Proprietary Name: Bortezomib	Injection	Intravenous	Maia Pharmaceuticals, Inc.	ACTIVE
70511-162	Bortezomib	Non-Proprietary Name: Bortezomib	Injection	Intravenous	Maia Pharmaceuticals, Inc.	ACTIVE
70710-1411	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Zydus Pharmaceuticals Usa Inc.	ACTIVE
70771-1708	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Zydus Lifesciences Limited	ACTIVE
71288-118	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Meitheal Pharmaceuticals Inc.	ACTIVE
72205-183	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Novadoz Pharmaceuticals Llc	ACTIVE
72266-243	Bortezomib	Non-Proprietary Name: Bortezomib	Injection	Intravenous	Fosun Pharma Usa Inc	ACTIVE
72266-244	Bortezomib	Non-Proprietary Name: Bortezomib	Injection	Intravenous	Fosun Pharma Usa Inc	ACTIVE
76075-101	Kyprolis	Non-Proprietary Name: Carfilzomib	Injection, Powder, Lyophilized, For Solution	Intravenous	Onyx Pharmaceuticals, Inc.	ACTIVE
76075-102	Kyprolis	Non-Proprietary Name: Carfilzomib	Injection, Powder, Lyophilized, For Solution	Intravenous	Onyx Pharmaceuticals, Inc.	ACTIVE
76075-103	Kyprolis	Non-Proprietary Name: Carfilzomib	Injection, Powder, Lyophilized, For Solution	Intravenous	Onyx Pharmaceuticals, Inc.	ACTIVE
83090-008	Bortezomib	Non-Proprietary Name: Bortezomib	Injection, Powder, Lyophilized, For Solution	Intravenous; Subcutaneous	Sintetica Us Llc	ACTIVE